Deferred Examination: A Solution Whose Time Has Come 12/03/2009 by Intellectual Property Watch 2 Comments With over 1 million patent applications backlogged at the US Patent & Trademark Office, IBM legal counsel Steven Bennett and David Kappos urge adoption of a deferred examination process, which they argue will benefit USPTO, applicants and the public.
Administrative Patent Validity Determinations If The Proposed US Patent Reform Act Of 2009 Passes 09/03/2009 by Intellectual Property Watch Leave a Comment On 3 March, 2009, bills were introduced in the US Congress setting forth the proposed “Patent Reform Act of 2009”. The legislation proposes significant changes to post-issuance proceedings available to challenge patents in the United States. US attorneys Matthew A. Smith, Stephen B. Maebius and Jon W. Dudas argue the proposed legislation will be a step toward improving patent quality.
Alarm Escalates Over Delayed Generic Drug Shipments As Action Sought 06/03/2009 by William New, Intellectual Property Watch 4 Comments Health advocates on Friday escalated their alarm over recent seizures by the Dutch government of shipments of legitimate generic pharmaceuticals passing through Europe on their way to developing countries. The European Commission has defended its actions as permissible under its own and international rules, but is being asked to look more carefully at those rules.
Concerns Continue Over Generic Drug Seizures As Legality Debates Begin 05/03/2009 by Kaitlin Mara for Intellectual Property Watch and William New 2 Comments Developing nations led by Brazil and India, along with public health providers and advocates, this week continue to press strong concern over seizures of legitimate shipments of generic pharmaceuticals destined for poor patients in the developing world. Raising the issue at the World Trade Organization again, they say new research into numerous shipments of legitimate drugs delayed by authorities in the Netherlands have elevated doubts and may mean potentially thousands of patients put at risk.
US Patent Reform Bills And Jobs: Critical Timing, Critical Differences 04/03/2009 by Liza Porteus Viana, Intellectual Property Watch 1 Comment The United States patent reform bills offered up Tuesday fall well short of what is needed to protect innovation and intellectual property rights, say myriad small tech companies, large-cap manufacturers, pharmaceutical firms and inventors. In fact, they say, it even threatens jobs at a time when the economy is in desperate need of them. But proponents argue that it is precisely the type of measure needed to promote jobs, reduce lawsuits and poor patent quality that put a drag on innovation and the economy.
Drug Patent Linkage Is Subject Of Court Case, Dispute In India 25/02/2009 by Monika Ermert for Intellectual Property Watch 1 Comment Should national drug control bodies grant marketing licences to generic medicine companies only if their products do not possibly infringe existing patent rights? Yes, German pharmaceutical company Bayer told the High Court of Delhi last week when the court heard arguments in an ongoing court case on patent linkage.
Industry Pushes For Biosimilars Approval Process; Some IGOs Take Notice 24/02/2009 by Kiernan A. Murphy for Intellectual Property Watch and Kaitlin Mara for Intellectual Property Watch Leave a Comment Key players in the biotechnology industry are leading an effort to obtain global approval processes for generic biological medicines, which experts say could provide cheaper access to costly but widely prescribed and promising treatments.
欧盟有关知识产权的强硬规定被视为对贫困国家医药获得的威胁 24/02/2009 by David Cronin for Intellectual Property Watch Leave a Comment 布鲁塞尔 – 全球公共卫生活跃分子声称，欧盟执意要在一系列自由贸易协议中添加有关医药专利的强硬规定将会妨害发展中国家获得医药。
لأحكام التجارية القوية للاتحاد الأوروبي حول الملكية الفكرية تعتبر تهديدا على نفاذ البلدان الفقيرة إلى الأدوية 24/02/2009 by David Cronin for Intellectual Property Watch Leave a Comment ابروكسل- إن الجهود التي يبذلها الاتحاد الأوروبي لإدراج أحكام حول براءات المستحضرات الصيدلانية في سلسلة من اتفاقات التجارة الحرة التي يتفاوض حولها قد تشكل تهديدا على إمكانية الحصول على الأدوية في البلدان النامية، على حد قول الناشطين في مجال الصحة العامة على الصعيد العالمي.
Des dispositions renforçant la propriété intellectuelle dans certains accords de l’UE menacent l’accès aux médicaments dans les pays pauvres 24/02/2009 by David Cronin for Intellectual Property Watch Leave a Comment BRUXELLES – Selon certains activistes de la santé publique mondiale, les efforts de l’Union européenne (UE) pour intégrer des dispositions sur les brevets pharmaceutiques dans un certain nombre d’accords de libre échange en cours de négociation pourraient mettre en péril l’accès aux médicaments dans les pays en développement.